SOC Telemed
soc key operating metrics total consults | SOC Telemed
Company
Deck Type
Deck date
January 2022
Slide
13 of 27
Related slides by other companies
Nuvalent
Investor Presentation
January 2024
potential best in class profile for opportunity to both move up the treatment paradigm grow the market with deep durable responses no clear standard of care soc mutation disease current soc of disease demonstrated activity where current available therapies have failed opportunity to supplant standard of care with a differentiated clinical activity observed in heavily patients with who likely exhausted all available therapies including after or with resistance mutations with history of metastasis including intracranial responses to address combined medical needs mutation coverage activity avoiding off target adverse events opportunity to drive deep durable responses favorable preliminary safety consistent with selective sparing design sources sales and forecasts accessed lin precision and lung cancer a | Nuvalent
Pershing Square
Activist
May 2013
gross margins big structural opportunity total | Pershing Square
OpenText
Investor Presentation
August 2022
a opportunity aligned with tam segmentation | OpenText
Semrush
Investor Day
October 2024
extensive opportunity and continued net new customer additions enterprise mid market total market opportunity | Semrush
Other recent decks by SOC Telemed
See all presentations (2 decks)
Investor Day
September 2020
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights